Published in Bioconjug Chem on November 19, 2004
Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA delivery. J Control Release (2009) 1.54
Navigare necessere est. Improved navigation would help to solve two crucial problems in modern drug therapy: toxicity and precise delivery. EMBO Rep (2005) 1.42
Enabling individualized therapy through nanotechnology. Pharmacol Res (2010) 1.28
Dendrimers as drug delivery vehicles: non-covalent interactions of bioactive compounds with dendrimers. Polym Int (2007) 1.07
A critical review of lipid-based nanoparticles for taxane delivery. Cancer Lett (2012) 0.89
Paclitaxel distribution in poly(ethylene glycol)/poly(lactide-co-glycolic acid) blends and its release visualized by coherent anti-Stokes Raman scattering microscopy. J Control Release (2007) 0.89
Influence of dendrimer surface charge on the bioactivity of 2-methoxyestradiol complexed with dendrimers. Soft Matter (2010) 0.85
Synthesis of Polyglycerol, Porphyrin-Cored Dendrimers Using Click Chemistry. European J Org Chem (2008) 0.84
Dendrimers for siRNA Delivery. Pharmaceuticals (Basel) (2013) 0.82
Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues. J Pharm Bioallied Sci (2014) 0.81
Poly(amido amine) dendrimers as absorption enhancers for oral delivery of camptothecin. Int J Pharm (2013) 0.80
Prodrug Strategies for Paclitaxel. Int J Mol Sci (2016) 0.75
Targeted drug delivery to tumors: myths, reality and possibility. J Control Release (2011) 2.69
Release of hydrophobic molecules from polymer micelles into cell membranes revealed by Forster resonance energy transfer imaging. Proc Natl Acad Sci U S A (2008) 2.16
Orally fast disintegrating tablets: developments, technologies, taste-masking and clinical studies. Crit Rev Ther Drug Carrier Syst (2004) 2.06
Polycation gene delivery systems: escape from endosomes to cytosol. J Pharm Pharmacol (2003) 1.92
Fast release of lipophilic agents from circulating PEG-PDLLA micelles revealed by in vivo forster resonance energy transfer imaging. Langmuir (2008) 1.88
Human extracellular matrix (ECM) powders for injectable cell delivery and adipose tissue engineering. J Control Release (2009) 1.70
Control of encapsulation efficiency and initial burst in polymeric microparticle systems. Arch Pharm Res (2004) 1.66
Hydrotropic polymer micelle system for delivery of paclitaxel. J Control Release (2005) 1.52
Overcoming the barriers in micellar drug delivery: loading efficiency, in vivo stability, and micelle-cell interaction. Expert Opin Drug Deliv (2010) 1.51
Analysis on the current status of targeted drug delivery to tumors. J Control Release (2012) 1.48
Tumor-homing multifunctional nanoparticles for cancer theragnosis: Simultaneous diagnosis, drug delivery, and therapeutic monitoring. J Control Release (2010) 1.37
Mechanisms of controlled drug release from drug-eluting stents. Adv Drug Deliv Rev (2006) 1.36
Molecular imprinting within hydrogels. Adv Drug Deliv Rev (2002) 1.36
Frosta: a new technology for making fast-melting tablets. Expert Opin Drug Deliv (2005) 1.33
Hydrotropic agents for study of in vitro paclitaxel release from polymeric micelles. J Control Release (2004) 1.31
Ginsenoside Rp1, a Ginsenoside Derivative, Blocks Promoter Activation of iNOS and COX-2 Genes by Suppression of an IKKβ-mediated NF-кB Pathway in HEK293 Cells. J Ginseng Res (2011) 1.26
Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs. Int J Pharm (2012) 1.25
Molecular mechanism of macrophage activation by red ginseng acidic polysaccharide from Korean red ginseng. Mediators Inflamm (2012) 1.24
Issues in long-term protein delivery using biodegradable microparticles. J Control Release (2010) 1.21
Superporous IPN hydrogels having enhanced mechanical properties. AAPS PharmSciTech (2003) 1.19
Hydrotropic polymeric micelles for enhanced paclitaxel solubility: in vitro and in vivo characterization. Biomacromolecules (2007) 1.18
Biodegradable polymers for microencapsulation of drugs. Molecules (2005) 1.18
Engineered polymers for advanced drug delivery. Eur J Pharm Biopharm (2008) 1.17
Akt Cys-310-targeted inhibition by hydroxylated benzene derivatives is tightly linked to their immunosuppressive effects. J Biol Chem (2010) 1.14
Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer. Colloids Surf B Biointerfaces (2011) 1.14
Elastic, superporous hydrogel hybrids of polyacrylamide and sodium alginate. Macromol Biosci (2006) 1.14
Accelerated chondrocyte functions on NaOH-treated PLGA scaffolds. Biomaterials (2005) 1.12
Hydrotropic solubilization of paclitaxel: analysis of chemical structures for hydrotropic property. Pharm Res (2003) 1.12
Effective repair of traumatically injured spinal cord by nanoscale block copolymer micelles. Nat Nanotechnol (2009) 1.12
Smart Polymeric Gels: Redefining the Limits of Biomedical Devices. Prog Polym Sci (2007) 1.11
Recent developments in superporous hydrogels. J Pharm Pharmacol (2007) 1.11
Functional role of Akt in macrophage-mediated innate immunity. Front Biosci (Landmark Ed) (2011) 1.08
Advances in superporous hydrogels. J Control Release (2005) 1.07
The hydrogel template method for fabrication of homogeneous nano/microparticles. J Control Release (2009) 1.07
Local drug delivery via a coronary stent with programmable release pharmacokinetics. Circulation (2003) 1.04
Inhibitory effect of saponin fraction from Codonopsis lanceolata on immune cell-mediated inflammatory responses. Arch Pharm Res (2009) 1.04
Tumor-homing poly-siRNA/glycol chitosan self-cross-linked nanoparticles for systemic siRNA delivery in cancer treatment. Angew Chem Int Ed Engl (2012) 1.04
High-performance liquid chromatographic determination of doxazosin in human plasma for bioequivalence study of controlled release doxazosin tablets. Biomed Chromatogr (2006) 1.03
Comparison of oral bioavailability of genistein and genistin in rats. Int J Pharm (2007) 1.03
Development of an in vitro 3D tumor model to study therapeutic efficiency of an anticancer drug. Mol Pharm (2013) 1.01
In vitro and in vivo anti-inflammatory effects of ethanol extract from Acer tegmentosum. J Ethnopharmacol (2010) 1.01
Hydrotropic solubilization of poorly water-soluble drugs. J Pharm Sci (2010) 1.01
Anti-inflammatory activity of ethanol extract derived from Phaseolus angularis beans. J Ethnopharmacol (2011) 1.01
Tumor-targeting hyaluronic acid nanoparticles for photodynamic imaging and therapy. Biomaterials (2012) 1.00
In situ visualization of paclitaxel distribution and release by coherent anti-Stokes Raman scattering microscopy. Anal Chem (2006) 1.00
Effects of ethylene glycol-based graft, star-shaped, and dendritic polymers on solubilization and controlled release of paclitaxel. J Control Release (2003) 0.98
Hydrotropic polymer micelles containing acrylic acid moieties for oral delivery of paclitaxel. J Control Release (2008) 0.97
Hydrotropic polymer micelles as versatile vehicles for delivery of poorly water-soluble drugs. J Control Release (2011) 0.97
In vitro and in vivo anti-inflammatory activities of Polygonum hydropiper methanol extract. J Ethnopharmacol (2011) 0.97
In vitro and in vivo test of PEG/PCL-based hydrogel scaffold for cell delivery application. J Control Release (2007) 0.96
The TRIF/TBK1/IRF-3 activation pathway is the primary inhibitory target of resveratrol, contributing to its broad-spectrum anti-inflammatory effects. Pharmazie (2011) 0.95
Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery. J Control Release (2013) 0.95
Inhibitory effect of Sanguisorba officinalis ethanol extract on NO and PGE₂ production is mediated by suppression of NF-κB and AP-1 activation signaling cascade. J Ethnopharmacol (2010) 0.95
Cell-permeable ceramides act as novel regulators of U937 cell-cell adhesion mediated by CD29, CD98, and CD147. Immunobiology (2009) 0.95
The inhibition of platelet adhesion and activation on collagen during balloon angioplasty by collagen-binding peptidoglycans. Biomaterials (2011) 0.94
Regulatory effects of Codonopsis lanceolata on macrophage-mediated immune responses. J Ethnopharmacol (2007) 0.94
A new hydrotropic block copolymer micelle system for aqueous solubilization of paclitaxel. J Control Release (2007) 0.94
Src/NF-κB-targeted inhibition of LPS-induced macrophage activation and dextran sodium sulphate-induced colitis by Archidendron clypearia methanol extract. J Ethnopharmacol (2012) 0.94
Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery. Adv Drug Deliv Rev (2012) 0.94
Tumor-homing photosensitizer-conjugated glycol chitosan nanoparticles for synchronous photodynamic imaging and therapy based on cellular on/off system. Biomaterials (2011) 0.93
A study of drug release from homogeneous PLGA microstructures. J Control Release (2010) 0.93
Specific adsorption of histidine-tagged proteins on silica surfaces modified with Ni2+/NTA-derivatized poly(ethylene glycol). Langmuir (2007) 0.93
Fabrication of porous extracellular matrix scaffolds from human adipose tissue. Tissue Eng Part C Methods (2010) 0.93
Fast-melting tablets based on highly plastic granules. J Control Release (2005) 0.93
Blood-stable, tumor-adaptable disulfide bonded mPEG-(Cys)4-PDLLA micelles for chemotherapy. Biomaterials (2012) 0.93
Effects of a Rubus coreanus Miquel supplement on plasma antioxidant capacity in healthy Korean men. Nutr Res Pract (2011) 0.92
Inhibition of Mitogen Activated Protein Kinase Activated Protein Kinase II with MMI-0100 reduces intimal hyperplasia ex vivo and in vivo. Vascul Pharmacol (2011) 0.92
Pharmaceutical evaluation of genistein-loaded pluronic micelles for oral delivery. Arch Pharm Res (2007) 0.92
Decellularized extracellular matrix derived from human adipose tissue as a potential scaffold for allograft tissue engineering. J Biomed Mater Res A (2011) 0.91
Hydrogen bonding interactions between adsorbed polymer molecules and crystal surface of acetaminophen. J Colloid Interface Sci (2005) 0.90
Hydrotropic oligomer-conjugated glycol chitosan as a carrier of paclitaxel: synthesis, characterization, and in vivo biodistribution. J Control Release (2009) 0.90
Paclitaxel distribution in poly(ethylene glycol)/poly(lactide-co-glycolic acid) blends and its release visualized by coherent anti-Stokes Raman scattering microscopy. J Control Release (2007) 0.89
Supramolecular design for multivalent interaction: maltose mobility along polyrotaxane enhanced binding with concanavalin A. J Am Chem Soc (2003) 0.88
A glucose sensor fabricated by piezoelectric inkjet printing of conducting polymers and bienzymes. Anal Sci (2011) 0.88
BSA-FITC-loaded microcapsules for in vivo delivery. Biomaterials (2008) 0.88
Nanobubbles from gas-generating polymeric nanoparticles: ultrasound imaging of living subjects. Angew Chem Int Ed Engl (2010) 0.87
Solvent exchange method: a novel microencapsulation technique using dual microdispensers. Pharm Res (2004) 0.87
Application of concave microwells to pancreatic tumor spheroids enabling anticancer drug evaluation in a clinically relevant drug resistance model. PLoS One (2013) 0.87
Application of poly(acrylic acid) superporous hydrogel microparticles as a super-disintegrant in fast-disintegrating tablets. J Pharm Pharmacol (2004) 0.87
Scaffold-free in vitro arterial mimetics: the importance of smooth muscle-endothelium contact. Tissue Eng Part A (2010) 0.87
Inhibition of cytokine expression by a butanol extract from Cordyceps bassiana. Pharmazie (2011) 0.87
In vitro-in vivo correlation: perspectives on model development. Int J Pharm (2011) 0.87
p38-targeted inhibition of interleukin-12 expression by ethanol extract from Cordyceps bassiana in lipopolysaccharide-activated macrophages. Immunopharmacol Immunotoxicol (2010) 0.87
Drug loading and release properties of ion-exchange resin complexes as a drug delivery matrix. Int J Pharm (2008) 0.87
Skin permeation enhancement of ascorbyl palmitate by liposomal hydrogel (lipogel) formulation and electrical assistance. Biol Pharm Bull (2007) 0.86
Development of a directly compressible poly(ethylene oxide) matrix for the sustained-release of dihydrocodeine bitartrate. Drug Dev Ind Pharm (2003) 0.86
A new process for making reservoir-type microcapsules using ink-jet technology and interfacial phase separation. J Control Release (2003) 0.86
Nuclear factor-kappaB/signal transducers and activators of transcription-1-mediated inflammatory responses in lipopolysaccharide-activated macrophages are a major inhibitory target of kahweol, a coffee diterpene. Biol Pharm Bull (2010) 0.86
In vitro and in vivo release of albumin using a biodegradable MPEG-PCL diblock copolymer as an in situ gel-forming carrier. Biomacromolecules (2007) 0.85
The ability of an ethanol extract of Cinnamomum cassia to inhibit Src and spleen tyrosine kinase activity contributes to its anti-inflammatory action. J Ethnopharmacol (2011) 0.85
Preparation and swelling behavior of chitosan-based superporous hydrogels for gastric retention application. J Biomed Mater Res A (2006) 0.85
Multivalent interactions between biotin-polyrotaxane conjugates and streptavidin as a model of new targeting for transporters. J Control Release (2002) 0.85
A pharma-robust design method to investigate the effect of PEG and PEO on matrix tablets. Int J Pharm (2010) 0.85
Design of deformable chitosan microspheres loaded with superparamagnetic iron oxide nanoparticles for embolotherapy detectable by magnetic resonance imaging. Carbohydr Polym (2012) 0.84
Regulatory effect of cinnamaldehyde on monocyte/macrophage-mediated inflammatory responses. Mediators Inflamm (2010) 0.84
Hydrotropic magnetic micelles for combined magnetic resonance imaging and cancer therapy. J Control Release (2012) 0.84